本周（指2025 年12 月15 日至19 日，下同）本周沪深300 下跌0.28%，医药生物下跌0.14%，处于31 个一级子行业第22 位，医药子板块中，化学制药、生物制品、医疗器械、医药商业、中药、医疗服务本周涨跌幅分别为-1.74%、-0.67%、1.16%、4.94%、0.17%、0.55%。临床前CRO 客户需求回暖，上游实验猴供给端紧张。受益于国内BD 出海大趋势，国内一级创新药行业...
Source Link本周（指2025 年12 月15 日至19 日，下同）本周沪深300 下跌0.28%，医药生物下跌0.14%，处于31 个一级子行业第22 位，医药子板块中，化学制药、生物制品、医疗器械、医药商业、中药、医疗服务本周涨跌幅分别为-1.74%、-0.67%、1.16%、4.94%、0.17%、0.55%。临床前CRO 客户需求回暖，上游实验猴供给端紧张。受益于国内BD 出海大趋势，国内一级创新药行业...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.